GlassScriptPhysician profile
Ronald Hessler
NPI 1629057443
$1,353.94
in general payments reported to CMS, 2019-2025
17 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.11 · 2020: $52.71 · 2021: $142 · 2022: $265 · 2023: $339 · 2024: $315 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $501.12 | 2019-2025 | Clareon, Hydrus Microstent, Eysuvis |
| Rxsight INC | $290.46 | 2022-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Abbvie INC. | $95.77 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $75.55 | 2023-2025 | Xiidra, Miebo |
| Novartis Pharmaceuticals Corporation | $57.32 | 2021-2022 | |
| Genentech USA, INC. | $50.75 | 2024 | Vabysmo |
| Oyster Point Pharma, INC. | $45.78 | 2022-2023 | Tyrvaya |
| Allergan, INC. | $44.52 | 2020-2021 | |
| Mindray Ds USA, INC. | $42.55 | 2025 | A7 Anesthesia System |
| Glaukos Corporation | $24.11 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $23.68 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $22.29 | 2023 | Eylea |
| Rayner Intraocular Lenses Limited | $20.17 | 2024 | Omidria |
| Aerie Pharmaceuticals, INC. | $17.78 | 2021 | |
| Sun Pharmaceutical Industries INC. | $17.15 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $12.96 | 2021 | |
| Biotissue Holdings INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Hessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.